Gene Symbol | Gene ID | Gene Info |
---|---|---|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_144385351_144385534 | PLAGL1 | 293 | 0.928612 | 0.88 | 1.6e-03 | Click! |
chr6_144385545_144385940 | PLAGL1 | 7 | 0.983933 | 0.74 | 2.1e-02 | Click! |
chr6_144384950_144385276 | PLAGL1 | 622 | 0.786092 | 0.68 | 4.2e-02 | Click! |
chr6_144376227_144376378 | PLAGL1 | 9433 | 0.246208 | 0.67 | 5.0e-02 | Click! |
chr6_144376696_144376868 | PLAGL1 | 8953 | 0.247402 | 0.65 | 6.0e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_39368986_39369494 | 2.97 |
RINL |
Ras and Rab interactor-like |
321 |
0.74 |
chr11_441689_441900 | 2.66 |
ANO9 |
anoctamin 9 |
217 |
0.82 |
chr19_6481304_6482171 | 2.59 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr5_1105065_1105874 | 2.47 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
6681 |
0.19 |
chr11_67204819_67205147 | 2.38 |
PTPRCAP |
protein tyrosine phosphatase, receptor type, C-associated protein |
555 |
0.47 |
chr17_76123581_76124282 | 2.25 |
TMC6 |
transmembrane channel-like 6 |
780 |
0.49 |
chr22_37545294_37545803 | 2.17 |
IL2RB |
interleukin 2 receptor, beta |
482 |
0.7 |
chr19_3179462_3180177 | 2.08 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1083 |
0.38 |
chr19_17439012_17439348 | 2.04 |
ANO8 |
anoctamin 8 |
6458 |
0.08 |
chr1_6525547_6525781 | 1.95 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
26 |
0.96 |
chr11_2322356_2322739 | 1.95 |
C11orf21 |
chromosome 11 open reading frame 21 |
596 |
0.44 |
chr1_1564774_1565122 | 1.90 |
MIB2 |
mindbomb E3 ubiquitin protein ligase 2 |
1079 |
0.29 |
chr2_162101279_162101855 | 1.89 |
AC009299.2 |
|
6106 |
0.21 |
chr16_29675034_29675898 | 1.88 |
QPRT |
quinolinate phosphoribosyltransferase |
866 |
0.35 |
chr17_45811642_45811793 | 1.86 |
TBX21 |
T-box 21 |
1107 |
0.44 |
chr19_17862364_17862733 | 1.83 |
FCHO1 |
FCH domain only 1 |
203 |
0.91 |
chr11_2322055_2322323 | 1.83 |
C11orf21 |
chromosome 11 open reading frame 21 |
954 |
0.34 |
chr3_13057259_13057549 | 1.82 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
28868 |
0.23 |
chr4_2801328_2801581 | 1.80 |
SH3BP2 |
SH3-domain binding protein 2 |
729 |
0.69 |
chr7_5436621_5436873 | 1.78 |
TNRC18 |
trinucleotide repeat containing 18 |
9087 |
0.16 |
chr19_55765720_55766271 | 1.78 |
PPP6R1 |
protein phosphatase 6, regulatory subunit 1 |
1142 |
0.27 |
chr14_105531321_105531563 | 1.76 |
GPR132 |
G protein-coupled receptor 132 |
325 |
0.89 |
chr22_40057938_40058206 | 1.74 |
CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit |
91314 |
0.07 |
chr4_8203061_8203388 | 1.70 |
SH3TC1 |
SH3 domain and tetratricopeptide repeats 1 |
2126 |
0.36 |
chr17_43325815_43326080 | 1.69 |
CTD-2020K17.4 |
|
241 |
0.73 |
chr9_140008700_140009150 | 1.68 |
DPP7 |
dipeptidyl-peptidase 7 |
231 |
0.78 |
chr20_35202518_35202795 | 1.65 |
TGIF2-C20orf24 |
TGIF2-C20orf24 readthrough |
300 |
0.44 |
chr11_2325355_2325506 | 1.60 |
TSPAN32 |
tetraspanin 32 |
1332 |
0.29 |
chr9_140009270_140009650 | 1.60 |
DPP7 |
dipeptidyl-peptidase 7 |
169 |
0.84 |
chr17_4389201_4389708 | 1.58 |
RP13-580F15.2 |
|
194 |
0.92 |
chr12_6744541_6744794 | 1.55 |
LPAR5 |
lysophosphatidic acid receptor 5 |
946 |
0.33 |
chr6_32159695_32160229 | 1.54 |
GPSM3 |
G-protein signaling modulator 3 |
683 |
0.42 |
chr17_73839317_73839828 | 1.52 |
UNC13D |
unc-13 homolog D (C. elegans) |
278 |
0.8 |
chr1_27286242_27286878 | 1.50 |
C1orf172 |
chromosome 1 open reading frame 172 |
337 |
0.84 |
chr1_1148809_1149188 | 1.49 |
TNFRSF4 |
tumor necrosis factor receptor superfamily, member 4 |
514 |
0.56 |
chr19_35738965_35739537 | 1.48 |
LSR |
lipolysis stimulated lipoprotein receptor |
44 |
0.95 |
chr11_67171589_67172183 | 1.48 |
TBC1D10C |
TBC1 domain family, member 10C |
226 |
0.8 |
chr17_43326081_43326290 | 1.47 |
CTD-2020K17.4 |
|
18 |
0.93 |
chr7_2561062_2561754 | 1.45 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
1912 |
0.27 |
chr1_27668600_27669070 | 1.44 |
SYTL1 |
synaptotagmin-like 1 |
322 |
0.82 |
chr17_43305596_43305797 | 1.44 |
CTD-2020K17.1 |
|
6107 |
0.1 |
chr6_35265630_35266434 | 1.44 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
403 |
0.84 |
chr22_50628950_50629632 | 1.43 |
TRABD |
TraB domain containing |
264 |
0.78 |
chr5_175460576_175460928 | 1.43 |
THOC3 |
THO complex 3 |
931 |
0.5 |
chr19_6772910_6773160 | 1.42 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
66 |
0.96 |
chr10_135089035_135089208 | 1.42 |
ADAM8 |
ADAM metallopeptidase domain 8 |
1233 |
0.29 |
chr19_54875923_54876565 | 1.42 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
170 |
0.91 |
chr17_43487096_43487739 | 1.42 |
ARHGAP27 |
Rho GTPase activating protein 27 |
335 |
0.82 |
chr19_10381283_10381454 | 1.41 |
ICAM1 |
intercellular adhesion molecule 1 |
143 |
0.88 |
chr19_42758603_42759183 | 1.41 |
ERF |
Ets2 repressor factor |
106 |
0.78 |
chr7_6544048_6544357 | 1.40 |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
20329 |
0.12 |
chr10_73847083_73847476 | 1.39 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
807 |
0.69 |
chr16_30484007_30484505 | 1.37 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
184 |
0.81 |
chr1_6525804_6526081 | 1.37 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
225 |
0.88 |
chr17_76121987_76122243 | 1.36 |
TMC6 |
transmembrane channel-like 6 |
986 |
0.4 |
chr19_872356_872546 | 1.36 |
CFD |
complement factor D (adipsin) |
12761 |
0.07 |
chr22_50050359_50050996 | 1.36 |
C22orf34 |
chromosome 22 open reading frame 34 |
401 |
0.87 |
chr10_134260489_134261029 | 1.35 |
C10orf91 |
chromosome 10 open reading frame 91 |
2066 |
0.3 |
chr1_154980554_154980872 | 1.34 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5418 |
0.08 |
chr13_24270271_24270700 | 1.34 |
AL139080.1 |
Uncharacterized protein |
51758 |
0.14 |
chr14_93117897_93118048 | 1.34 |
RIN3 |
Ras and Rab interactor 3 |
874 |
0.71 |
chr1_1136399_1136824 | 1.34 |
TNFRSF18 |
tumor necrosis factor receptor superfamily, member 18 |
4449 |
0.09 |
chr19_50003270_50003501 | 1.34 |
hsa-mir-150 |
hsa-mir-150 |
396 |
0.48 |
chr1_154981512_154981710 | 1.33 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5313 |
0.08 |
chr2_219724214_219724365 | 1.33 |
WNT6 |
wingless-type MMTV integration site family, member 6 |
255 |
0.88 |
chr11_64981486_64981735 | 1.33 |
CAPN1 |
calpain 1, (mu/I) large subunit |
30803 |
0.08 |
chr4_8200922_8201607 | 1.32 |
SH3TC1 |
SH3 domain and tetratricopeptide repeats 1 |
166 |
0.96 |
chr22_24823622_24823773 | 1.32 |
ADORA2A |
adenosine A2a receptor |
167 |
0.95 |
chr21_45661777_45662023 | 1.32 |
ICOSLG |
inducible T-cell co-stimulator ligand |
1051 |
0.37 |
chr5_176858230_176858507 | 1.32 |
GRK6 |
G protein-coupled receptor kinase 6 |
4513 |
0.11 |
chr17_48046517_48046834 | 1.32 |
DLX4 |
distal-less homeobox 4 |
19 |
0.97 |
chr1_101702315_101703350 | 1.32 |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
388 |
0.67 |
chr19_3721754_3721946 | 1.31 |
TJP3 |
tight junction protein 3 |
115 |
0.93 |
chr19_42703347_42703984 | 1.30 |
ENSG00000265122 |
. |
6435 |
0.1 |
chr16_88812444_88812728 | 1.30 |
RP5-1142A6.8 |
|
3357 |
0.1 |
chr17_75453810_75454179 | 1.29 |
SEPT9 |
septin 9 |
1546 |
0.33 |
chr8_142255255_142255924 | 1.29 |
RP11-10J21.4 |
|
7802 |
0.15 |
chr11_2292275_2292426 | 1.29 |
ASCL2 |
achaete-scute family bHLH transcription factor 2 |
168 |
0.93 |
chr17_73840046_73840332 | 1.29 |
UNC13D |
unc-13 homolog D (C. elegans) |
226 |
0.84 |
chr11_73087458_73087910 | 1.29 |
RELT |
RELT tumor necrosis factor receptor |
29 |
0.97 |
chr19_13206703_13207270 | 1.28 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
6695 |
0.11 |
chr5_175963745_175963953 | 1.28 |
RNF44 |
ring finger protein 44 |
572 |
0.64 |
chr11_1594496_1594647 | 1.28 |
KRTAP5-AS1 |
KRTAP5-1/KRTAP5-2 antisense RNA 1 |
84 |
0.94 |
chr16_31487995_31488231 | 1.28 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
3366 |
0.11 |
chr3_197282263_197282715 | 1.28 |
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
340 |
0.92 |
chr12_4378605_4379089 | 1.28 |
CCND2 |
cyclin D2 |
4091 |
0.19 |
chr7_139875207_139876022 | 1.27 |
KDM7A |
lysine (K)-specific demethylase 7A |
1127 |
0.39 |
chr16_23847524_23848074 | 1.27 |
PRKCB |
protein kinase C, beta |
396 |
0.89 |
chr17_61775506_61775979 | 1.27 |
LIMD2 |
LIM domain containing 2 |
780 |
0.58 |
chr8_144821797_144821966 | 1.27 |
FAM83H |
family with sequence similarity 83, member H |
5910 |
0.08 |
chr16_27413508_27414237 | 1.26 |
IL21R |
interleukin 21 receptor |
377 |
0.88 |
chr21_46902934_46903368 | 1.26 |
COL18A1 |
collagen, type XVIII, alpha 1 |
7038 |
0.21 |
chr14_105527312_105527781 | 1.26 |
GPR132 |
G protein-coupled receptor 132 |
3727 |
0.23 |
chr19_16022503_16022872 | 1.25 |
CYP4F2 |
cytochrome P450, family 4, subfamily F, polypeptide 2 |
13757 |
0.16 |
chr11_1873160_1873311 | 1.25 |
LSP1 |
lymphocyte-specific protein 1 |
965 |
0.36 |
chr1_156785806_156786457 | 1.25 |
SH2D2A |
SH2 domain containing 2A |
495 |
0.51 |
chr20_57582513_57582791 | 1.25 |
CTSZ |
cathepsin Z |
350 |
0.84 |
chr17_79895341_79895621 | 1.25 |
PYCR1 |
pyrroline-5-carboxylate reductase 1 |
57 |
0.91 |
chr17_56410108_56410593 | 1.25 |
MIR142 |
microRNA 142 |
481 |
0.66 |
chr3_27763469_27763904 | 1.25 |
EOMES |
eomesodermin |
117 |
0.98 |
chr22_46409167_46409603 | 1.24 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
36376 |
0.09 |
chr17_80010093_80010791 | 1.24 |
GPS1 |
G protein pathway suppressor 1 |
333 |
0.62 |
chr19_50002450_50002748 | 1.23 |
hsa-mir-150 |
hsa-mir-150 |
1182 |
0.15 |
chr9_35649649_35650491 | 1.23 |
SIT1 |
signaling threshold regulating transmembrane adaptor 1 |
867 |
0.32 |
chr15_77287809_77288285 | 1.23 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
132 |
0.96 |
chr19_3180285_3180457 | 1.23 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1635 |
0.26 |
chr9_92112533_92112719 | 1.23 |
ENSG00000264913 |
. |
227 |
0.56 |
chr17_80260072_80260536 | 1.23 |
CD7 |
CD7 molecule |
15124 |
0.1 |
chr9_132250998_132251163 | 1.22 |
ENSG00000264298 |
. |
10245 |
0.21 |
chr9_129484934_129485155 | 1.21 |
ENSG00000266403 |
. |
4432 |
0.26 |
chr12_48213585_48213859 | 1.21 |
HDAC7 |
histone deacetylase 7 |
22 |
0.97 |
chr12_58240274_58240425 | 1.20 |
CTDSP2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
138 |
0.92 |
chr14_71787375_71787676 | 1.20 |
SIPA1L1 |
signal-induced proliferation-associated 1 like 1 |
583 |
0.62 |
chr8_143557259_143557713 | 1.20 |
BAI1 |
brain-specific angiogenesis inhibitor 1 |
12109 |
0.21 |
chr2_233926000_233926302 | 1.20 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
962 |
0.56 |
chr17_80274635_80275020 | 1.20 |
CD7 |
CD7 molecule |
601 |
0.6 |
chr19_10405987_10406645 | 1.19 |
ICAM5 |
intercellular adhesion molecule 5, telencephalin |
4663 |
0.08 |
chr19_39227882_39228286 | 1.19 |
CTD-2540F13.2 |
|
840 |
0.4 |
chr19_6669805_6670171 | 1.19 |
TNFSF14 |
tumor necrosis factor (ligand) superfamily, member 14 |
140 |
0.94 |
chr7_2550958_2551215 | 1.19 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
1077 |
0.47 |
chr10_105211794_105212415 | 1.18 |
CALHM2 |
calcium homeostasis modulator 2 |
29 |
0.88 |
chr11_65184608_65185159 | 1.18 |
ENSG00000245532 |
. |
27046 |
0.09 |
chr22_25961017_25961859 | 1.18 |
ADRBK2 |
adrenergic, beta, receptor kinase 2 |
622 |
0.55 |
chr2_127838932_127839401 | 1.18 |
BIN1 |
bridging integrator 1 |
25411 |
0.22 |
chr7_38389357_38389573 | 1.17 |
AMPH |
amphiphysin |
113248 |
0.07 |
chr19_7414677_7414948 | 1.17 |
CTB-133G6.1 |
|
964 |
0.51 |
chr16_28303969_28304444 | 1.17 |
SBK1 |
SH3 domain binding kinase 1 |
366 |
0.88 |
chr8_22551556_22552015 | 1.16 |
EGR3 |
early growth response 3 |
970 |
0.44 |
chr4_1796827_1797107 | 1.16 |
FGFR3 |
fibroblast growth factor receptor 3 |
1344 |
0.42 |
chr19_18112722_18113118 | 1.16 |
ARRDC2 |
arrestin domain containing 2 |
979 |
0.48 |
chr17_30771533_30772357 | 1.16 |
PSMD11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
422 |
0.79 |
chr16_3014681_3015078 | 1.15 |
KREMEN2 |
kringle containing transmembrane protein 2 |
357 |
0.69 |
chr17_3598807_3599359 | 1.15 |
P2RX5 |
purinergic receptor P2X, ligand-gated ion channel, 5 |
244 |
0.86 |
chr17_76127983_76128228 | 1.15 |
TMC6 |
transmembrane channel-like 6 |
383 |
0.71 |
chr20_61734160_61734508 | 1.15 |
ENSG00000225978 |
. |
851 |
0.62 |
chr22_50987475_50987644 | 1.15 |
KLHDC7B |
kelch domain containing 7B |
1097 |
0.24 |
chr17_80279192_80279518 | 1.15 |
CD7 |
CD7 molecule |
3877 |
0.13 |
chr12_15113209_15113383 | 1.14 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
904 |
0.55 |
chr19_1077655_1078093 | 1.14 |
HMHA1 |
histocompatibility (minor) HA-1 |
432 |
0.68 |
chr16_31488490_31488831 | 1.14 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
3913 |
0.1 |
chr15_34658899_34659312 | 1.14 |
LPCAT4 |
lysophosphatidylcholine acyltransferase 4 |
374 |
0.77 |
chr19_50180106_50180536 | 1.14 |
PRMT1 |
protein arginine methyltransferase 1 |
9 |
0.93 |
chr7_151079002_151079235 | 1.14 |
NUB1 |
negative regulator of ubiquitin-like proteins 1 |
13202 |
0.12 |
chr19_17439707_17439937 | 1.14 |
ANO8 |
anoctamin 8 |
5816 |
0.08 |
chr11_2324787_2325062 | 1.14 |
TSPAN32 |
tetraspanin 32 |
826 |
0.45 |
chr6_90122075_90122308 | 1.13 |
RRAGD |
Ras-related GTP binding D |
202 |
0.94 |
chr15_75494605_75495154 | 1.13 |
C15orf39 |
chromosome 15 open reading frame 39 |
333 |
0.82 |
chrX_128914480_128914899 | 1.13 |
SASH3 |
SAM and SH3 domain containing 3 |
729 |
0.68 |
chr1_53018865_53019016 | 1.13 |
ZCCHC11 |
zinc finger, CCHC domain containing 11 |
168 |
0.96 |
chr18_77159557_77160137 | 1.13 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
475 |
0.86 |
chr5_180230026_180230861 | 1.13 |
MGAT1 |
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
38 |
0.97 |
chr16_67679075_67679512 | 1.13 |
RLTPR |
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
143 |
0.91 |
chr9_139515430_139515687 | 1.13 |
ENSG00000252440 |
. |
18591 |
0.09 |
chr9_137288293_137289070 | 1.12 |
RXRA |
retinoid X receptor, alpha |
9747 |
0.23 |
chr6_90121716_90121871 | 1.12 |
RRAGD |
Ras-related GTP binding D |
4 |
0.98 |
chr17_56415064_56415366 | 1.11 |
BZRAP1-AS1 |
BZRAP1 antisense RNA 1 |
496 |
0.64 |
chr17_63556671_63556918 | 1.11 |
AXIN2 |
axin 2 |
119 |
0.98 |
chr20_57582980_57583192 | 1.11 |
CTSZ |
cathepsin Z |
784 |
0.56 |
chr4_90228457_90229530 | 1.11 |
GPRIN3 |
GPRIN family member 3 |
168 |
0.97 |
chr17_40440858_40441114 | 1.11 |
STAT5A |
signal transducer and activator of transcription 5A |
425 |
0.75 |
chr16_29611589_29612053 | 1.11 |
ENSG00000266758 |
. |
1235 |
0.4 |
chr11_67187527_67187749 | 1.11 |
PPP1CA |
protein phosphatase 1, catalytic subunit, alpha isozyme |
1014 |
0.26 |
chr19_1468668_1469018 | 1.11 |
ENSG00000267317 |
. |
6079 |
0.07 |
chr21_46339892_46340194 | 1.10 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
727 |
0.4 |
chr16_87889371_87889596 | 1.10 |
SLC7A5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
7762 |
0.18 |
chr1_201084105_201084501 | 1.10 |
ASCL5 |
achaete-scute family bHLH transcription factor 5 |
493 |
0.75 |
chr9_140353920_140354271 | 1.10 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
309 |
0.83 |
chr15_41220159_41220535 | 1.10 |
DLL4 |
delta-like 4 (Drosophila) |
1244 |
0.34 |
chr22_50969510_50970103 | 1.10 |
ODF3B |
outer dense fiber of sperm tails 3B |
700 |
0.36 |
chr19_8273493_8273858 | 1.10 |
CERS4 |
ceramide synthase 4 |
512 |
0.76 |
chrX_48775697_48776218 | 1.10 |
PIM2 |
pim-2 oncogene |
344 |
0.77 |
chr9_130740055_130740787 | 1.09 |
FAM102A |
family with sequence similarity 102, member A |
2371 |
0.18 |
chr11_64631996_64632371 | 1.09 |
EHD1 |
EH-domain containing 1 |
10955 |
0.1 |
chr6_25027724_25027911 | 1.09 |
ENSG00000244618 |
. |
3693 |
0.22 |
chr9_134127628_134128133 | 1.09 |
FAM78A |
family with sequence similarity 78, member A |
18000 |
0.15 |
chr1_153517024_153517533 | 1.09 |
S100A4 |
S100 calcium binding protein A4 |
261 |
0.8 |
chr16_89555877_89556212 | 1.09 |
ANKRD11 |
ankyrin repeat domain 11 |
682 |
0.55 |
chr17_40540005_40540435 | 1.09 |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
212 |
0.9 |
chr19_48828473_48828624 | 1.09 |
EMP3 |
epithelial membrane protein 3 |
34 |
0.96 |
chr2_202050412_202050706 | 1.09 |
CASP10 |
caspase 10, apoptosis-related cysteine peptidase |
2641 |
0.22 |
chr9_136150814_136151142 | 1.08 |
ENSG00000201843 |
. |
26975 |
0.09 |
chr7_3083277_3083584 | 1.08 |
CARD11 |
caspase recruitment domain family, member 11 |
49 |
0.98 |
chr9_129485287_129485658 | 1.08 |
ENSG00000266403 |
. |
4860 |
0.26 |
chr19_17906212_17906758 | 1.08 |
B3GNT3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
519 |
0.69 |
chr7_101460259_101460698 | 1.08 |
CUX1 |
cut-like homeobox 1 |
404 |
0.87 |
chr22_42353959_42354205 | 1.07 |
CENPM |
centromere protein M |
10914 |
0.1 |
chr17_48503622_48503808 | 1.07 |
ACSF2 |
acyl-CoA synthetase family member 2 |
102 |
0.94 |
chr17_77006003_77006327 | 1.07 |
CANT1 |
calcium activated nucleotidase 1 |
216 |
0.91 |
chr16_744734_744885 | 1.07 |
FBXL16 |
F-box and leucine-rich repeat protein 16 |
1216 |
0.17 |
chr4_2813961_2814292 | 1.07 |
SH3BP2 |
SH3-domain binding protein 2 |
95 |
0.97 |
chr17_32965108_32965375 | 1.06 |
TMEM132E |
transmembrane protein 132E |
57473 |
0.13 |
chr16_29676024_29676411 | 1.06 |
QPRT |
quinolinate phosphoribosyltransferase |
1617 |
0.24 |
chr22_19879311_19879851 | 1.06 |
GNB1L |
guanine nucleotide binding protein (G protein), beta polypeptide 1-like |
37119 |
0.1 |
chr14_90084669_90085459 | 1.06 |
FOXN3 |
forkhead box N3 |
410 |
0.78 |
chr13_113622985_113623455 | 1.06 |
MCF2L-AS1 |
MCF2L antisense RNA 1 |
82 |
0.79 |
chr19_38908265_38908571 | 1.05 |
RASGRP4 |
RAS guanyl releasing protein 4 |
8384 |
0.09 |
chr18_77154529_77155196 | 1.05 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
994 |
0.62 |
chr12_125052371_125052867 | 1.05 |
NCOR2 |
nuclear receptor corepressor 2 |
609 |
0.84 |
chr19_16771265_16771741 | 1.05 |
TMEM38A |
transmembrane protein 38A |
435 |
0.38 |
chr19_4379861_4380304 | 1.04 |
SH3GL1 |
SH3-domain GRB2-like 1 |
207 |
0.85 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.7 | 5.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.6 | 4.9 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.3 | 5.2 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.2 | 3.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.2 | 5.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.1 | 3.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.1 | 4.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.1 | 3.2 | GO:0048143 | astrocyte activation(GO:0048143) |
1.0 | 1.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
1.0 | 6.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
1.0 | 3.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
1.0 | 1.0 | GO:0051497 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
0.9 | 1.8 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.9 | 1.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.9 | 0.9 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.8 | 2.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.8 | 2.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 2.4 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.8 | 1.6 | GO:0001705 | ectoderm formation(GO:0001705) |
0.8 | 0.8 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.8 | 8.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.8 | 3.8 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.7 | 17.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.7 | 2.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.7 | 2.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.7 | 2.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.7 | 1.4 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.7 | 4.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.7 | 1.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.7 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.7 | 0.7 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.7 | 1.3 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.7 | 2.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.6 | 1.3 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.6 | 1.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 2.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.6 | 1.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.6 | 1.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.6 | 1.3 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.6 | 1.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.6 | 1.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.6 | 2.5 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.6 | 0.6 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.6 | 1.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.6 | 0.6 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.6 | 1.2 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.6 | 1.2 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.6 | 1.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.6 | 3.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.6 | 1.8 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.6 | 0.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 3.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 1.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.6 | 0.6 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.6 | 1.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 2.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.6 | 2.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.6 | 1.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 2.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 0.6 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.6 | 2.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.6 | 2.8 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.6 | 1.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.6 | 0.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 2.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.6 | 1.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.6 | 2.8 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.5 | 1.6 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.5 | 0.5 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.5 | 0.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.5 | 1.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 1.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 1.6 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.5 | 5.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.5 | 3.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.5 | 0.5 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.5 | 8.8 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.5 | 8.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.5 | 1.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 0.5 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.5 | 2.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 1.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.5 | 2.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 1.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.5 | 2.0 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 1.5 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) auditory receptor cell fate determination(GO:0042668) inner ear receptor cell fate commitment(GO:0060120) |
0.5 | 2.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.5 | 1.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.5 | 1.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.5 | 0.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 0.5 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.5 | 2.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 2.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.5 | 2.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.5 | 1.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 2.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.5 | 1.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.5 | 2.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 1.9 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.5 | 1.9 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.5 | 4.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.5 | 1.4 | GO:0001821 | histamine secretion(GO:0001821) |
0.5 | 0.5 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.5 | 1.9 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.5 | 2.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.8 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.5 | 1.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 1.4 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.5 | 0.5 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.4 | 0.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 2.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 1.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.4 | 2.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 0.9 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.4 | 0.4 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
0.4 | 1.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.4 | 1.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 0.9 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.4 | 1.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.4 | 1.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 2.2 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.4 | 3.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 2.6 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.4 | 0.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 4.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.4 | 8.1 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.4 | 1.7 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.4 | 19.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.4 | 2.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 1.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.4 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 0.8 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.4 | 1.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.4 | 0.4 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.4 | 0.8 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.4 | 1.6 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.4 | 1.6 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 0.4 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.4 | 2.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 1.2 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.4 | 1.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.4 | 3.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.4 | 1.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 0.8 | GO:0032329 | serine transport(GO:0032329) |
0.4 | 0.8 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.4 | 5.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 2.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 2.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 1.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 1.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 1.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.4 | 2.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 3.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 1.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 1.2 | GO:0043276 | anoikis(GO:0043276) |
0.4 | 1.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 1.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 1.2 | GO:1902743 | regulation of lamellipodium assembly(GO:0010591) regulation of lamellipodium organization(GO:1902743) |
0.4 | 1.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 1.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.4 | 1.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 1.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.4 | 1.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.4 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 1.5 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.4 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.4 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.4 | 0.4 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.4 | 1.5 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.4 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 3.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.4 | 1.1 | GO:0015809 | arginine transport(GO:0015809) |
0.4 | 0.7 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.4 | 1.5 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.4 | 1.8 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.4 | 0.4 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.4 | 0.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 3.3 | GO:0042026 | protein refolding(GO:0042026) |
0.4 | 0.4 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.4 | 1.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.4 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 0.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.4 | 3.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 1.8 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.4 | 0.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.4 | 2.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.4 | 0.4 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.4 | 1.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.4 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 1.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.3 | 1.4 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.3 | 1.4 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 3.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.3 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.3 | 0.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 5.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.4 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.3 | 3.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 1.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 2.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.3 | GO:0015853 | adenine transport(GO:0015853) |
0.3 | 1.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 0.7 | GO:0035246 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
0.3 | 1.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 0.7 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.3 | 3.0 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.3 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.3 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
0.3 | 2.0 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.3 | 0.3 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.3 | 3.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 0.3 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.3 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.3 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.3 | 0.3 | GO:1903513 | protein exit from endoplasmic reticulum(GO:0032527) endoplasmic reticulum to cytosol transport(GO:1903513) |
0.3 | 1.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.3 | 2.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.3 | 0.3 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.3 | 1.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 0.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 0.6 | GO:0070293 | renal absorption(GO:0070293) |
0.3 | 13.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.3 | 1.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 0.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 2.8 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.3 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.9 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.3 | 0.3 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.3 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 0.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.6 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 1.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 1.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 0.6 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.3 | 2.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.6 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.3 | 0.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 0.9 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.3 | 3.9 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.3 | 0.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.3 | 0.3 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.3 | 0.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 2.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.3 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 1.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 2.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.3 | 0.9 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.3 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 1.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 1.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
0.3 | 0.3 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 2.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 13.9 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 1.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 0.9 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.3 | 0.9 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 0.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 0.8 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 1.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 0.8 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.3 | 0.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 2.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 0.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.3 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.3 | 1.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 0.6 | GO:0015851 | nucleobase transport(GO:0015851) |
0.3 | 0.3 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.3 | 3.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.3 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) negative regulation of striated muscle cell differentiation(GO:0051154) histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.3 | 0.3 | GO:0033483 | gas homeostasis(GO:0033483) |
0.3 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.3 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.8 | GO:1902579 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.3 | 1.4 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 1.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.5 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 0.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.3 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.3 | 1.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.5 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.3 | 1.1 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.3 | 0.5 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.3 | 0.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.3 | 1.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 1.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 0.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 1.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.3 | 0.8 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.3 | 1.0 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.3 | 0.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 | 1.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.3 | 0.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.3 | 1.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 1.3 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.3 | 2.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 2.5 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.3 | 0.5 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.5 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.3 | 1.3 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.8 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.3 | 2.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.3 | 4.3 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 1.0 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 2.3 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 1.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 0.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 4.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.2 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.2 | 0.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.2 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.2 | GO:0032606 | type I interferon production(GO:0032606) |
0.2 | 0.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 0.5 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 1.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 0.7 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.5 | GO:0048668 | collateral sprouting(GO:0048668) regulation of collateral sprouting(GO:0048670) |
0.2 | 0.7 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 1.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.7 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 1.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.7 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.2 | 0.7 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 1.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.5 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.7 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.2 | 0.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.2 | 0.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.7 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.9 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 2.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.2 | 6.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 1.8 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.2 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 3.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 0.7 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.2 | 1.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.7 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.2 | 0.7 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.2 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 1.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.2 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.2 | 0.9 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 0.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 0.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 4.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 1.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 1.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.9 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.4 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 5.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.7 | GO:0045010 | actin nucleation(GO:0045010) |
0.2 | 0.4 | GO:0007549 | dosage compensation(GO:0007549) |
0.2 | 1.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 2.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.4 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 0.6 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.2 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.4 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 3.0 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.2 | 0.6 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.2 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 2.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.8 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 1.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.4 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 1.0 | GO:0061462 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.2 | 1.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 4.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 1.4 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 0.4 | GO:0097576 | vacuole fusion(GO:0097576) |
0.2 | 3.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 1.2 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.2 | 3.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 3.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 0.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.8 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 2.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.2 | 0.6 | GO:0000239 | pachytene(GO:0000239) |
0.2 | 8.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 1.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.2 | 6.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 1.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.6 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.2 | 0.8 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.2 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.0 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 1.0 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.2 | 3.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 3.5 | GO:0030183 | B cell differentiation(GO:0030183) |
0.2 | 5.2 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.2 | GO:0032107 | regulation of response to extracellular stimulus(GO:0032104) regulation of response to nutrient levels(GO:0032107) |
0.2 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.4 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 1.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.2 | 2.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.8 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 4.7 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 2.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 1.5 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.2 | 0.4 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 8.9 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 2.4 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.2 | 0.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.2 | 4.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 2.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 2.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.9 | GO:0050663 | cytokine secretion(GO:0050663) |
0.2 | 1.1 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.2 | 1.4 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 10.8 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.2 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 1.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.2 | 5.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.9 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.2 | 1.6 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 0.3 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.2 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 2.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 1.6 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.2 | 2.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
0.2 | 0.2 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.2 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 1.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.7 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.2 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.6 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.2 | 0.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 1.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.2 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.2 | 1.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 0.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 2.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 6.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 0.3 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.2 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 2.4 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.2 | 0.6 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.3 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 0.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 1.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.8 | GO:0009304 | tRNA transcription(GO:0009304) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 1.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 2.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 0.6 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.2 | 13.6 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.2 | 2.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 1.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 1.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 2.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 5.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 1.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.9 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.1 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.1 | 0.4 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.9 | GO:0072401 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 2.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.3 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.1 | 0.3 | GO:0006906 | vesicle fusion(GO:0006906) |
0.1 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 1.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 0.4 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 1.8 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:2001235 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 2.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 1.8 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 5.8 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.7 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.1 | 1.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 1.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 2.4 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.1 | 0.5 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 1.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 1.2 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 22.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 1.2 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.1 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 1.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 1.9 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.3 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.3 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 4.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.4 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.6 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 0.4 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.4 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 4.4 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.4 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 1.3 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.1 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.6 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 10.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.1 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.5 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.2 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
0.1 | 0.5 | GO:1990542 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 9.9 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.5 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 3.2 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 1.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 8.8 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 10.7 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.1 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.9 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.6 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.7 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.1 | GO:1903051 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 1.9 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.1 | 6.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.5 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 1.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.4 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.1 | GO:2000108 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of leukocyte apoptotic process(GO:2000108) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 2.9 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.4 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 1.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.2 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 3.7 | GO:0009135 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) ribonucleoside diphosphate metabolic process(GO:0009185) |
0.1 | 0.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.4 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 5.1 | GO:0006364 | rRNA processing(GO:0006364) rRNA metabolic process(GO:0016072) |
0.1 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 2.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.1 | 0.4 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.4 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.2 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.1 | 0.3 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.6 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.3 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 6.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.3 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.3 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 5.1 | GO:0019080 | viral gene expression(GO:0019080) viral transcription(GO:0019083) |
0.1 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.9 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 0.2 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.1 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 3.3 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.1 | 0.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 2.2 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.9 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.4 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 1.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.8 | GO:0006325 | chromatin organization(GO:0006325) |
0.1 | 0.8 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 2.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.1 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.1 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.1 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 0.5 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.1 | 0.4 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.5 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.2 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 0.5 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.1 | 3.9 | GO:0009144 | purine nucleoside triphosphate metabolic process(GO:0009144) ATP metabolic process(GO:0046034) |
0.1 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 2.3 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 1.9 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.9 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 1.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 6.1 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.5 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.6 | GO:0048925 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.1 | 1.4 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 1.9 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.1 | 0.5 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 0.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.5 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.1 | 0.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 0.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.8 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.4 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.1 | GO:0033238 | regulation of cellular amine metabolic process(GO:0033238) |
0.1 | 0.1 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.9 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0001711 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) endodermal cell differentiation(GO:0035987) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 2.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 1.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 2.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0043414 | macromolecule methylation(GO:0043414) |
0.1 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 1.3 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 0.6 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 3.7 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.3 | GO:0016045 | detection of bacterium(GO:0016045) |
0.1 | 1.1 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 2.4 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.0 | 0.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.0 | GO:0071503 | response to heparin(GO:0071503) |
0.0 | 0.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.2 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 5.5 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.2 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism(GO:0043903) |
0.0 | 0.2 | GO:0034660 | ncRNA metabolic process(GO:0034660) |
0.0 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 3.0 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.0 | 0.6 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.1 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.8 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.0 | 0.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.0 | 4.6 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0016458 | gene silencing(GO:0016458) |
0.0 | 0.0 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.0 | 0.3 | GO:0006027 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.1 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:1904892 | regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
0.0 | 1.2 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.0 | 0.0 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.3 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0009451 | RNA modification(GO:0009451) |
0.0 | 0.0 | GO:0032392 | DNA geometric change(GO:0032392) DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.0 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.0 | 0.0 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.3 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.0 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.2 | GO:0070820 | tertiary granule(GO:0070820) |
1.1 | 4.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.8 | 2.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 9.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.8 | 2.3 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 2.2 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.7 | 2.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 2.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.7 | 2.7 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.6 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 3.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 2.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 4.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 1.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 5.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 1.6 | GO:0031904 | endosome lumen(GO:0031904) |
0.5 | 2.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 4.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.5 | 3.0 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.5 | 1.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.5 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.5 | 0.9 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.5 | 0.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 1.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 3.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 7.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.4 | 5.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 2.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 2.0 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 1.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.4 | 2.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.4 | 1.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 1.5 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.4 | 1.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 4.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 2.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 1.8 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 2.8 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.3 | 3.1 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 2.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 2.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 4.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 1.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 1.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 4.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 6.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 9.8 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 2.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 0.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 0.3 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.3 | 2.5 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.3 | 7.4 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.3 | 1.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 0.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 2.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 0.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 2.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.9 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 0.9 | GO:0001652 | granular component(GO:0001652) |
0.3 | 3.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 2.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 4.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 1.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 2.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 3.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 1.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 3.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.0 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.3 | 0.8 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.3 | 1.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.5 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.3 | 1.8 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 16.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 4.4 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 13.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 3.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.9 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 21.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.7 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 2.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 3.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 2.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.4 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.2 | 1.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 1.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 1.1 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 2.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.6 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.2 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.4 | GO:0031967 | organelle envelope(GO:0031967) |
0.2 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 3.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 2.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 1.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 6.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 5.2 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.2 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 2.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.8 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 7.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 7.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 15.1 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 1.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.0 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.0 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 5.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 1.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 3.4 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.2 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.0 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 2.3 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.5 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.7 | GO:0000803 | sex chromosome(GO:0000803) |
0.2 | 1.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 9.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 2.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 0.3 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.2 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.8 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.2 | 0.6 | GO:0033011 | perinuclear theca(GO:0033011) |
0.2 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 32.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.1 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 2.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 2.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 5.6 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 8.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 5.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.6 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.6 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 3.3 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 2.6 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.3 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 22.7 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 4.8 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 6.7 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 5.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 4.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 2.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 8.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 3.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 3.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 2.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 8.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 3.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 2.6 | GO:0030496 | midbody(GO:0030496) |
0.1 | 2.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 4.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 4.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.7 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 1.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 3.6 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 2.0 | GO:0031248 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 3.7 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 4.2 | GO:0005819 | spindle(GO:0005819) |
0.1 | 14.6 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 4.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 2.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 1.6 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 35.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.1 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.1 | 0.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 2.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 2.7 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 99.5 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 46.8 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 10.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 1.6 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.2 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 26.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 3.3 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.8 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 10.4 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.5 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 137.4 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 14.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 7.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 1.4 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 3.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 2.7 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.7 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 1.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.0 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 2.6 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.7 | 5.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.2 | 3.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.2 | 4.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.0 | 1.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.9 | 11.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.9 | 2.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.9 | 4.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.8 | 1.6 | GO:0070061 | fructose binding(GO:0070061) |
0.7 | 3.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 2.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.7 | 2.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 3.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.7 | 3.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.7 | 2.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 2.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 2.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 1.4 | GO:0005035 | death receptor activity(GO:0005035) |
0.7 | 2.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.7 | 2.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 3.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 1.9 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.6 | 3.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 0.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.6 | 9.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 1.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.6 | 1.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 1.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 1.6 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 3.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.5 | 2.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.5 | 1.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.5 | 1.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 3.1 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 3.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 1.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 1.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 3.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 2.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 1.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 9.4 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 2.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 2.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.5 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 1.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 1.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.5 | 1.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 1.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.5 | 4.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.5 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.5 | 1.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.5 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 1.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 3.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 2.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 1.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 1.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 1.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 3.4 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 1.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 3.8 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 1.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 2.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 0.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 4.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 1.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 3.6 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.4 | 1.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.4 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 1.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.4 | 3.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 2.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 2.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.4 | 1.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.4 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.9 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 1.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 1.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 3.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 2.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 1.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 2.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 1.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.0 | GO:0046980 | tapasin binding(GO:0046980) |
0.3 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 2.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 4.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 13.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.3 | 1.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 4.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 9.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) glycogen phosphorylase activity(GO:0008184) |
0.3 | 0.7 | GO:0015184 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.3 | 1.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 1.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 2.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 5.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 1.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 2.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 1.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 0.9 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.3 | 3.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.3 | 4.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 15.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 5.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 1.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.3 | 3.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 2.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 1.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 1.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 2.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.8 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.3 | 0.3 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 1.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.3 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 1.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 1.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.3 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 0.9 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.6 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.3 | 5.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.7 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 0.5 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.3 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 4.0 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.3 | 0.8 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 3.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 0.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.3 | 3.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 0.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 1.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 0.8 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 0.8 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 4.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 0.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 2.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 1.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 2.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 2.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 1.7 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 2.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 1.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 2.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 1.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 1.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 3.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 5.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 2.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 7.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 3.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 2.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 5.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 10.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 4.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 1.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 5.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 0.8 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.2 | 4.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 1.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 3.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 4.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 1.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 2.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 2.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 3.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.2 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 1.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 1.2 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.2 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.2 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.2 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.2 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.6 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 15.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.2 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 3.0 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.2 | 5.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 1.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.6 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 2.0 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.2 | 1.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.4 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.2 | 1.6 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.2 | 0.7 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 3.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 3.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 3.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 1.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 8.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 3.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.7 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.3 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.2 | 3.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 2.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.2 | 2.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 1.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.8 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.2 | 17.3 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.2 | 6.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 1.9 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.2 | 1.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 3.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.9 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 5.3 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 1.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 1.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 0.8 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 3.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 3.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 1.9 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 3.4 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.7 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 2.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 8.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 2.3 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 1.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 4.4 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 3.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.6 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.9 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.0 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.6 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 5.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 1.9 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 2.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 13.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 5.3 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 14.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 4.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 1.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.4 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 14.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 3.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 7.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 2.3 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.1 | 1.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 7.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 1.9 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.1 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 1.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 39.3 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.6 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 2.0 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 2.6 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.7 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 12.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 2.1 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 8.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.3 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 4.4 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.2 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.5 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 1.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.1 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.7 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 5.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 3.1 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 1.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.4 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 1.8 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 1.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 65.8 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 3.7 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 5.5 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 1.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.1 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 5.5 | GO:0030695 | GTPase regulator activity(GO:0030695) nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.5 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.6 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 4.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.0 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 17.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 47.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.6 | 10.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 4.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 3.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 7.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 4.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 7.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 1.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 1.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 3.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 3.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 1.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 6.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 3.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 6.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 2.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 16.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 4.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 12.8 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 4.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 5.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 4.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 8.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 6.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 4.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 6.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 2.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 4.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 6.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 1.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 3.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 9.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 4.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 13.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 4.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 1.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 2.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 11.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 3.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 8.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 12.3 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 1.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 5.4 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 1.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 1.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 3.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 2.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 1.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 3.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 4.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 6.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 2.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 3.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 1.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 1.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 5.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 3.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 4.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.2 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 3.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 4.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 5.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.0 | 1.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.0 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.0 | 1.0 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.8 | 0.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.8 | 10.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 4.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 11.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.6 | 10.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.5 | 6.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 2.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.5 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 0.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.5 | 7.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 7.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 0.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.4 | 10.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 4.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.4 | 6.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 2.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 6.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 6.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 7.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.4 | 15.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 0.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.3 | 6.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 4.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 3.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 5.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 7.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.3 | 4.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 1.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 1.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 8.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 2.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 0.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 1.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 7.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 9.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 6.5 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 4.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 2.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 2.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 3.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 0.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 5.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 13.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 6.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 4.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 1.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 2.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 11.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 3.8 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 5.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 4.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 2.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 1.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 1.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 1.7 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 3.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 4.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 1.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 0.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 7.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 2.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 0.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.2 | 2.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 2.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 2.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 1.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 3.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 1.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 1.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 3.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 6.1 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.2 | 3.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 2.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 4.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 3.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 15.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 5.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 10.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 2.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 3.6 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 4.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 0.7 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 4.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 3.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 0.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 3.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 3.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 2.9 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 4.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 4.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 3.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 19.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 4.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 4.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 8.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 1.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 7.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 6.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 2.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 15.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 1.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.7 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 3.1 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 4.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 1.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 4.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 2.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.8 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 1.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.2 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 4.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 1.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 3.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.5 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.9 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.0 | 0.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 6.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |